TP53 and neoplasm: Evaluating NK-mediated lysis of tumor cells at several E:T ratios (online supplemental Fig. S3), demonstrated that 22RV1 and DU145 have different levels of baseline sensitivity to NK-mediated killing, which could in part be attributed to p53’s promotion of tumor cell recognition and killing by NK cells [22].